产品名称
ORBO™ Amberlite™ XAD-2 管, W,W,W separators, O.D. × L 8 mm × 110 mm, pkg of 50 ea
material
W,W,W separators
agency
NIOSH 2534,2537
product line
Amberlite™
ORBO™
composition
Bed A, 400 mg
Bed B, 200 mg
packaging
pkg of 50 ea
manufacturer/tradename
ORBO™ 609
technique(s)
active air sampling: suitable
O.D. × L
8 mm × 110 mm
matrix
XAD-2
particle size
20-50 mesh
application(s)
air monitoring
environmental
industrial hygiene
Quality Level
正在寻找类似产品? 访问 产品对比指南
General description
ORBO™ 609 Amberlite™ XAD®-2 (20/50)，400/200 mg吸附剂管（W,W,W 分离器，O.D. × L 8 mm × 110 mm）含有两个由玻璃丝或泡沫分开的相同的选择性吸附剂床层，用于气体和蒸汽采样。管的双层或双床层结构使得较小的后备床层可以捕集穿漏的样品。
Legal Information
Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Bruno Laeng et al.
Cognitive processing, 12(1), 13-21 (2010-09-25)
We recorded the pupil diameters of participants performing the words' color-naming Stroop task (i.e., naming the color of a word that names a color). Non-color words were used as baseline to firmly establish the effects of semantic relatedness induced by
[Explorative abrasion--obsolete?].
A Orbo
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 111(19), 2397-2398 (1991-08-20)
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持